To support this conclusion, our immunostaining analysis detected a positive correlation between USP22 and EZH2, which were both negatively associated with tumoral β2M expression and CD8+ T cell infiltration in human breast, colon, prostate, and lung cancers. This evidence concerns the gene USP22 and lung cancer.